Tunitas Therapeutics Garners $10,000,000 Series A Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8fb52495-d228-434a-b94c-75dabd9bfff5
Date
10/1/2015
Company Name
Tunitas Therapeutics
Mailing Address
409 Illinois Street San Francisco, CA 94158 USA
Company Description
Tunitas Therapeutics is a biopharmaceutical company that is developing novel and precisely targeted protein therapeutics with the potential to dramatically change the lives of allergy sufferers.
Website
http://www.tunitastherapeutics.com
Transaction Type
Venture Equity
Transaction Amount
$10,000,000
Transaction Round
Series A
Proceeds Purposes
The funding will also be used to continue the development of Tunitas’ pipeline of novel targeted vaccines for the treatment of specific allergies.
M&A Terms
Venture Investor
Ally Bridge Group
Venture Investor
WuXi PharmaTech